Assertio Holdings | DEPO - Gross Profit On Sales

Stock Price
12.38
Daily Change
0.17 1.35%
Monthly
21.20%
Yearly
-1.97%
Q1 Forecast
0.88

Assertio Holdings reported $22.24M in Gross Profit on Sales for its fiscal quarter ending in June of 2024.





Gross Profit On Sales Change Date
ANI Pharmaceuticals USD 111.79M 1.68M Sep/2025
Assertio Holdings USD 22.24M 970K Jun/2024
Aurora Cannabis CAD 32.29M 4.34M Sep/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Daiichi Sankyo JPY 439.83B 95.05B Dec/2025
Ironwood Pharmaceuticals USD 85.24M 44.1M Jun/2025
J&J USD 16.6B 118M Dec/2025
Knight Therapeutics CAD 44.83M 9.96M Jun/2025
Merck USD 13.42B 431M Sep/2025
Nektar Therapeutics USD 13.75M 650K Jun/2024
Omeros USD -33.16M 18.52M Jun/2024
Pfizer USD 3.54B 7.61B Sep/2025
Teva Pharmaceutical Industries USD 2.66B 351M Dec/2025